Jeff Hopmayer Joins Voodoo Scientific in A Board Capacity and With Investment To Support Its Breakthrough Innovation for the Spirits Industry

Voodoo Scientific, the innovators behind the first-ever technology that enables distillers to eliminate harshness from their spirits, is pleased to announce Jeff Hopmayer is joining Voodoo Scientific in a Board capacity and as an investor.

Hopmayer is best known as the founder of Brindiamo Group, a full-service whiskey partner that provides comprehensive solutions for sourcing, managing, and investing in premium whiskey. The company has evolved from a premier sourcing firm into a global leader in whiskey innovation, offering tailored services to brands, distilleries, and investors across the United States, United Kingdom, Ireland, and beyond. Jeff also served as a longtime board member at Bardstown Bourbon Company.

“Jeff has a deep understanding of the spirits industry globally, and has also been an innovator and business-builder his entire career. His track record of helping some of the most successful spirits brands grow from concept to category leaders, combined with his personal commitment to supporting entrepreneurs, means we have the best-of-the-best in our corner. For Jeff, it’s not just about what he does but it’s also about how he is doing it. We’re excited for what’s to come!” said Dr. Joana Montenegro, Chief Science Officer and co-founder.

“After retiring from Brindiamo I had decided to take some time off from business life, however, I have recently agreed to step into a Board spot with Voodoo Scientific because I was totally blown away by the science and then the physical taste test.” said Hopmayer. “This will change beverage alcohol in an amazing fashion, and I want to be part of it!”

Jeff’s involvement comes at an exciting time for Voodoo Scientific as they expand their conversations with prospective customers to select their initial brand partners for their commercial launch.  With their US-approved patent now also filed in over 20 countries globally, and with the manufacturing now beginning with a world-class manufacturer, the focus will shift toward cultivating a curated set of brands that launch innovative commercial spirits using Voodoo Scientific’s Viriato enzyme technology.

“Conversations with spirits companies have been universally enthusiastic.” said Dr. Montenegro. “With the early commercial availability of our Viriato product expected mid-2026, we are looking forward to continuing these collaborative discussions on their plans for innovative new products, such as new premium platforms, innovation on flavors, and of course delivering new heights in smoothness for spirits products. Many luminaries have entrusted Jeff to help create their iconic spirits brands, and we appreciate his unique perspectives as we strive to add value to our customers, and their consumers.”